Variables | Total (777) | Q 1 ≤3.0 (197) | Q 2 3.0-5.7 (195) | Q 3 5.7-9.5 (191) | Q 4 >9.5 (194) | P-value |
---|---|---|---|---|---|---|
Age (years), median (IQR) | 71 (62-78) | 69 (61-77) | 70 (62-78) | 71 (62-78) | 72 (63-79) | 0.623 |
Sex (male), n (%) | 420 (54.1%) | 104 (52.8%) | 100 (51.3%) | 109 (57.1%) | 107 (55.2%) | 0.677 |
Time from onset to admission (hours), median (IQR) | 11 (3-25) | 9 (3-22) | 13 (4-28) | 12 (4-27) | 8 (3-27) | 0.156 |
NIHSS score on admission, median (IQR) | 4 (3-8) | 5 (3-8) | 5 (3-8) | 4 (3-6) | 4 (3-8) | 0.389 |
Thrombolytic therapy, n (%) | 31 (4.0%) | 11 (5.6%) | 2 (1.0%) | 7 (3.7%) | 11 (5.7%) | 0.064 |
SBP (mmHg), median (IQR) | 150 (140-170) | 155 (140-170) | 150 (140-163) | 150 (140-170) | 150 (130-170) | 0.861 |
DBP (mmHg), median (IQR) | 89 (80-95) | 87 (80-95) | 90 (80-95) | 90 (80-98) | 89 (80-95) | 0.929 |
Previous stroke, n (%) | 185 (23.8%) | 42 (21.3%) | 50 (25.6%) | 45 (23.6%) | 48 (24.7%) | 0.769 |
Hypertension, n (%) | 547 (70.4%) | 139 (70.6%) | 143 (73.3%) | 129 (67.5%) | 136 (70.1%) | 0.667 |
Diabetes, n (%) | 179 (23.0%) | 43 (21.8%) | 49 (25.1%) | 43 (22.5%) | 44 (22.7%) | 0.876 |
Coronary heart disease, n (%) | 37 (4.8%) | 9 (4.6%) | 13 (6.7%) | 8 (4.2%) | 7 (3.6%) | 0.516 |
Atrial fibrillation, n (%) | 113 (14.5%) | 28 (14.2%) | 27 (13.8%) | 18 (9.4%) | 40 (20.6%) | 0.020 |
Heart failure, n (%) | 23 (3.0%) | 4 (2.0%) | 5 (2.6%) | 5 (2.6%) | 9 (4.6%) | 0.443 |
Smoking history, n (%) | 210 (27.0%) | 51 (25.9%) | 47 (24.1%) | 58 (30.4%) | 54 (27.8%) | 0.548 |
Drinking history, n (%) | 166 (21.4%) | 42 (21.3%) | 39 (20.0%) | 48 (25.1%) | 37 (19.1%) | 0.487 |
WBC (×109/L), median (IQR) | 6.4 (5.3-8.1) | 6.8 (5.6-8.5) | 6.3 (5.0-7.8) | 6.7 (5.4-8.3) | 6.3 (5.1-7.9) | 0.032 |
Platelet (×109/L), median (IQR) | 178 (143-217) | 185 (150-225) | 173 (139-217) | 182 (151-216) | 170 (138-205) | 0.072 |
Hemoglobin concentration (g/L), median (IQR) | 135 (123-146) | 134 (121-145) | 134 (123-146) | 136 (127-146) | 134 (124-145) | 0.373 |
ALB (g/L), mean (SD) | 38.5 (3.3) | 38.6 (3.3) | 38.8 (3.3) | 38.6 (3.4) | 38.3 (3.2) | 0.666 |
ALT (U/L), median (IQR) | 19 (13-26) | 19 (13-25) | 19 (13-27) | 18 (14-25) | 19 (14-28) | 0.941 |
AST (U/L), median (IQR) | 23 (19-28) | 23 (19-28) | 23 (19-28) | 22 (19-27) | 23 (19-27) | 0.546 |
Blood glucose (mmol/L), median (IQR) | 5.5 (4.9-6.7) | 5.7 (5.0-6.9) | 5.6 (4.8-7.0) | 5.4 (4.9-6.3) | 5.5 (5.0-6.7) | 0.537 |
TG (mmol/L), median (IQR) | 1.3 (0.9-1.8) | 1.2 (0.9-1.7) | 1.3 (0.9-1.9) | 1.4 (1.0-1.9) | 1.3 (0.9-1.9) | 0.173 |
TC (mmol/L), median (IQR) | 4.6 (3.9-5.3) | 4.7 (3.9-5.2) | 4.6 (3.9-5.3) | 4.5 (3.9-5.3) | 4.5 (3.9-5.2) | 0.976 |
LDL-C (mmol/L), mean (SD) | 2.7 (0.9) | 2.7 (0.8) | 2.8 (1.0) | 2.7 (0.9) | 2.6 (0.9) | 0.577 |
HDL-C (mmol/L), median (IQR) | 1.3 (1.0-1.5) | 1.3 (1.0-1.5) | 1.2 (1.1-1.5) | 1.2 (1.0-1.5) | 1.3 (1.0-1.6) | 0.510 |
SCr (µmoI/L), median (IQR) | 72 (60-84) | 70 (59-84) | 72 (62-83) | 72 (61-82) | 71 (57-85) | 0.900 |
Uric acid (µmoI/L), median (IQR) | 304 (234-381) | 287 (223-379) | 303 (238-387) | 308 (237-380) | 310 (238-381) | 0.655 |